ABBREVIATIONS
A common challenge among children with these conditions is delayed or disordered motor development, which affects a child's development across domains. Perceptualmotor experiences allow a child to participate and function in every moment, and are integral to cognitive development. 8, 9 In children with CP, a lower level of fine motor skills is a precursor to delayed development of numeracy. 10 Children with DCD exhibit delays in social and emotional development, seen in their lower self-worth, higher levels of anxiety, and the perception of themselves as being less competent and having less social support. 11 The health and developmental consequences of growing up with childhood-onset neurological conditions are undoubtedly severe, but the consequences to the families caring for these children are also extremely high. The caregiver burden includes negative effects on finances, family stress, physical and mental health, family functioning, and social interaction. 12 A study of 207 caregivers in India showed that almost half of the families were below the poverty line, while more than two-thirds of the families had mild to severe depression and more than two-thirds had mild to severe anxiety. 13 With such prevalent and pervasive impacts, identifying the most effective interventions for these neuromotor conditions is critical to improving the well-being of all involved.
There are currently a wide range of strategies being used to address the motor issues associated with lifelong neurological conditions, such as hippotherapy, constraintinduced movement strategies, and sensory processing techniques. No matter the strategy used, researchers have identified three important components known to drive neuroplastic brain changes and improve functional outcomes in individuals with neuromotor conditions: practice must be task-specific; delivered at a high volume; and directed towards goals that are meaningful for the child and family. [14] [15] [16] While therapists have become skilled at incorporating meaningful, task-specific practice into their plans of care, they struggle to achieve high-volume practice both during and outside therapy sessions. 17 Although regular homeexercise programs, involving children and their caregivers, are seen as a crucial part of achieving the volume of practice necessary to drive change, 18, 19 these programs can easily become 'chores' that challenge the motivation of children and parents to sustain these activities over time. 15 A study of caregivers of children with disabilities showed that 66% of the caregivers were non-compliant with the home exercise programs. 20 One solution to the challenge of using home programs to boosting volume of practice is to embed practice of functional tasks into existing daily routines. For children, daily routines often include video games, with play times for children averaging 1.25 hours per day. 21 Furthermore, 94% of American school-aged children were reported to have played some form of electronic game in the previous 6 months. 22 In this context, the recent trend towards incorporating active video gaming (AVG) into therapeutic plans of care and home activity programs makes sense. There has been an unprecedented increase in gaming technologies that could potentially serve as rehabilitation tools. Examples of AVG products available include EyeToy for Sony PlayStation 2, PlayStation 3 Move, Nintendo Wii/ Wii-U, Kinect for Microsoft's Xbox 360/Xbox One, dance mats, etc., which require the users to move various limbs or their entire bodies to play the games.
Use of AVG technology in children with neurological conditions is gaining popularity; however, evidence for its efficacy as a therapeutic intervention is inconsistent. 24 Hammond et al. reported significant improvement in motor skills with AVG training, 25 while Ferguson et al. and Smits-Engelman et al. found neuromotor task training to be more effective in improving motor proficiency than AVG. 26, 27 Current systematic reviews have focused on AVG as a method of addressing obesity and general physical health in children and adults, as well as identifying specific conditions, primarily of adults, in which AVG might be effective. 28 The two existing systematic reviews that have evaluated AVG as a motor skill therapy had a narrow focus on children with CP and included studies that constituted low-level evidence and used non-commercially available AVG. Currently, no clear recommendations as a motor intervention are available to assist clinicians, families, and other stakeholders in making decisions about the use of AVG.
Thus the purpose of this study is to systematically review evidence about the use of AVG as a therapeutic intervention for improving motor outcomes in children with neuromotor conditions. Specifically, the following parameters will be examined: health conditions in which AVG has been used, strength of the available evidence, delivery methods or systems for AVG, capacity for adjusting to individual needs and skill levels, effectiveness for achieving outcomes, and challenges/limitations in researching AVG. Bringing together the evidence on these parameters will assist practitioners, patients, and families in making decisions about how and when to incorporate AVG designed to improve functional movement into physical therapy plans of care for children with movement disorders. This information will assist in the design of future therapeutic technologies for this population.
METHOD
This systematic review was completed in accordance with the American Academy for Cerebral Palsy and Developmental Medicine (AACPDM) methodology, 29, 30 and the PRISMA checklist for systematic reviews. 31 The study was also registered with the PROSPERO international prospective register of systematic reviews (registration number CRD42015029147). 32 Studies included in this review investigated commercially available AVG used for improving movement-related outcomes across all levels of the International Classification of Functioning, Disability and Health (ICF) in children aged 2 to 17 years with neuromotor disorders affecting movement. The focus on commercially available systems, widely accessible to clinicians, was made in an attempt to maximize the usefulness of this review. Studies classified as systematic reviews, randomized control trials, and longitudinal studies were included in this analysis.
What this paper adds
• Gaming is used more frequently for intervention than for data collection in cerebral palsy, developmental coordination disorder, and Down syndrome.
• Active video gaming (AVG) demonstrates potential to improve impairments and outcomes in these populations.
• AVG was more beneficial as an intervention when used with direct clinical supervision.
• Choosing specific games was the most frequent method for individualizing tasks or difficulty levels.
• Limitations generally focused on threats to internal validity of research, not on problems with AVG technology. The term 'virtual reality,' although often used to refer to commercially available systems, was not included as a search term in an effort to exclude articles studying the developing technology of true virtual reality, in which the user is immersed in a computer-generated, full three-dimensional environment. Virtual reality/augmented reality are new avenues that can and should be examined in the future, as new commercial products are now on the market, for example Oculus Rift, HTC Vive, Sony PlayStation VR, Samsung Gear VR, Google Cardboard. However, it should be noted that the virtual reality systems vary greatly in terms cost, equipment, environment, and experience. This variability currently makes commercial virtual reality very difficult to assess; thus, we excluded systems described as virtual reality from our study. We believe our chosen terms offered enough redundancy to access all studies researching commercially available AVG. Filters used included English language only, participant age range 2 to 17 years, and publication date between January 2005 and December 2015. Once articles were retrieved, their references were reviewed for additional relevant literature. Two reviewers (LP and RM) independently determined inclusion eligibility for each article. In cases where consensus between reviewers could not be reached, disagreements were resolved by consulting an additional member of the research team (RH). Levels of evidence for each study were rated according to the evidence categorization of the Centre for Evidence-based Medicine (Table SI, online supporting information) , 33 as well as the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Quality of Evidence Rating Scheme (Table SII, online supporting information). 34 Studies using single-subject research designs were evaluated using the AACPDM Single Subject Design Levels of Evidence and Conduct Quality Ratings scales. 35 The types of specific outcome addressed by the studies were not limited to specific movement outcomes a priori, because we hoped to discover the range of movementrelated outcomes being addressed by AVG in the literature. However, studies excluded from this review included those that focused on weight control or fitness/obesity; used robotics, virtual reality, or non-commercially available systems; involved progressive disorders; did not address movement needs of the target population or include a motor outcome; did not include the use of AVG; were case studies or narrative reviews; were not available in English; were published before the year 2005 or after 2015; or planned projects that were incomplete or constituted gray literature. 29 Once the studies were identified, the following data were extracted and analysed: AVG use in specific neuromotor conditions; strength of the evidence; delivery methods or systems for AVG; capacity for adjusting exercise dosing to fit individual needs and skill levels; effectiveness for achieving outcomes; and the challenges and limitations described in each study.
RESULTS
The initial 2602 articles found were filtered to the final 20 using the described systematic review methodology (Fig. S1 , online supporting information, for flow diagram; Table SIII , online supporting information, for details). Data extracted from the 18 group design studies are reported in Table SIV (online supporting information). Data extracted from the two single-subject research design studies are reported in Table SV (online supporting information). The findings on the chosen parameters are described below.
Sample populations by health condition
Included studies focused on children with a variety of health conditions involving the nervous system including CP (n=9), DCD (n=6), Down syndrome (n=2), developmental delay (n=1), progressive spinocerebellar ataxia (n=1), and acquired brain injury (n=1). Hereafter, diagnostic categories with only one paper are grouped together and categorized as 'other' for the results and discussion. Across health conditions, most authors defined their sample within a specific age range, severity limits, or status related to safety factors such as postoperative activity restrictions. Combining samples of all included studies created a collective population of 606 children with ages from 3 to 20 years (mean 9.0). (Samples reported in the two systematic reviews were excluded from this count, either because the reviews did not include summarized demographic data, or because the reviews' data included articles that did not meet the criteria for this systematic review. The results of these two previously existing systematic reviews are summarized in the 'Effectiveness for achieving outcomes' section, below.) Additional characteristics of participants are detailed in Table I .
Strength of evidence
All included studies using group research designs were ranked using the levels of the Centre for Evidence-based Medicine. 33 These articles included 14 level 1, three level 2, and one level 3 group design studies, as well as two level 1 single-subject research design studies. As per the AACPDM methodology, group design studies in levels 1 to 3 (n=18) were also rated using the GRADE 34 system. Six studies were rated as high quality, four as moderate, and eight low. The two single-subject research design studies were rated as high quality. Details of ratings and methodologies of the studies are found in Table SVI (online supporting information). Although GRADE 34 rankings are provided, study parameters were neither homogenous nor extensive enough to allow rated recommendations.
Delivery methods or systems for AVG
The purpose, manner, and setting of delivering AVG experiences to participants also varied across included studies. Most studies (n=15) used AVG as an intervention tool only, while others also used it to collect performance data (n=3). All of the original research studies used one of three existing commercial gaming systems as their foundation. The Nintendo Wii or Wii Fit was used in 14 studies, PlayStation 2 EyeToy was used in three studies, and the Microsoft Xbox 360 Kinect system was used in two studies (one study used both the Kinect and the EyeToy). The details about how often each gaming system was used for the different health conditions are summarized in Figure 1 .
Gaming experiences were delivered under the supervision of a therapist in a clinic (n=10), in a school setting (n=4), or unsupervised at home (n=5) (one study delivered AVG in a clinic initially, and then switched to home). The remaining two studies were systematic reviews, and as such did not directly administer gaming strategies themselves under any particular condition. When AVG was used as the primary intervention approach, it seemed to be most beneficial when the children were directly supervised during play. 25, [36] [37] [38] [39] [40] [41] [42] [43] [44] Details about how often each delivery type was used across the different health conditions are summarized in Figure 2 .
Frequency and duration of AVG play varied across studies. Of the 18 studies that were not systematic reviews, there were 16 different AVG dosages, ranging from 10 minutes to 1 hour; less than once per week to 5 days per week; and for durations of 3 to 24 weeks. The only dosing strategy repeated across studies delivered AVG for 30 minutes, three times per week, for 6 weeks.
Capacity for adjusting to individual needs and skill levels
There were no articles in the final extraction that studied commercially available, customizable games that could be adjusted by the therapist or the client. Any articles that involved customizable gaming software described the development and the usability of new technology that was not yet commercially available. Therefore, in the accepted articles, the 'control' options available to the therapist involved choosing specific games for the children to play (n=3), or setting specific, pre-programmed difficulty levels (n=3). In the remaining studies (n=12), the children were allowed to choose any game to play from a pre-set list of games available and to choose their own difficulty level. Figure 3 summarizes the control choices made by the researchers studying the different populations of children. 
Effectiveness for achieving outcomes
Across the 18 original studies included in this systematic review, there were 49 different outcome measures used, which evaluated upper extremity function, lower extremity function, balance, or additional related factors (such as motivation). Results for each of these functional variables were not consistent. Some outcome measures showed significant improvement with AVG training, while others demonstrated no effect. Most (n=36) of these outcome measures assessed the children's abilities at the activity level of the ICF. Six outcome measures assessed impairments, and two evaluated participation.
CP
Across the nine studies evaluating children with CP, there were 20 outcome measures used. There was no repetition of outcome measures across studies: that is, no single outcome measure was used in more than one study. Nine outcome measures assessed upper extremity function, including hand function, grip strength, coordination, manual dexterity, ball skills, and general function. Most of these studies exhibited significant improvement after AVG training. However, AVG did not prove to be significantly more effective than standard care. Studies using six balance outcomes demonstrated mixed results. Three outcome measures evaluated lower extremity function, including stair climbing, walking, and running/agility. Walking improved after AVG training, but there were no improvements in stair climbing ability or running/agility performance. Researchers reported on four additional outcome measures of caregivers' perceptions, motivation, participation, and child satisfaction. All were tested in the same study and showed more improvement than the control condition of standard care. Most of these outcome measures assessed children at the ICF activity level, with one outcome measure assessing participation and one assessing impairments.
There were also two systematic reviews that studied this population. Both agreed that there was not enough highquality evidence to fully support AVG use, and that the studies they found did not share similar study designs to compare results. Bonnech ere et al. stated that the reviewed studies had mostly positive results, indicating improvements in muscle strength, balance, motivation and participation, performance, and bone density. 45 However, they also emphasized that none of these results was backed by strong evidence. Fehlings et al. reported mixed results for upper limb function and for increases in cardiovascular fitness, but found strongly supported positive results for lower-limb gross motor function. 46 This review also reported that AVG was able to provide moderate levels of activity for children.
DCD
Across the six articles that studied children with DCD, there were 16 different outcome measures used. Only the Movement Assessment Battery for Children -Second Edition and the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition were used more than once. The Movement Assessment Battery for Children tests manual dexterity, ball skills, and balance. Half of the studies using this test showed improvement after AVG training, and half showed no effect. The Bruininks-Oseretsky Test evaluates fine motor precision and integration, manual dexterity, bilateral coordination, balance, running speed and agility, upper limb coordination, and strength. Children's scores on all subtests except running speed and agility increased after AVG training. Of the remaining tests, three evaluated upper extremity function (specifically coordination and strength), two tested balance skills, and six tested lower-extremity function (including walking, running, coordination, and strength). Overall, there was not a significant difference in strength before and after AVG training, and the test results for balance and the upper extremities were mixed. However, there was significant improvement on most of the tests for the lower extremities. Once again, these tests were all mostly focused on the activity level of the ICF, with three tests for impairments and one for participation.
Down syndrome
Three outcome measures were used across the two studies for this population. The children's scores for the Bruininks-Oseretsky Test, described above, improved after AVG training. The remaining two outcome measures evaluated visual perception, motor coordination, postural movement control, and various sensory and behavioral abilities. There was improvement in the scores of these two tests as well. When compared with standard care, AVG training demonstrated better results in a few test subsections and worse results in others.
Other
Across the three articles in this population group, there were 16 outcome measures used. Three of these evaluated the upper extremity function (strength, coordination, gross motor); three tested balance; nine tested the lower extremity function (walking, strength, stairs, gross motor, coordination); and three looked at children's and parents' Review 907 perceptions of skills. Results for balance and perception outcomes were mixed. However, all other outcome measures showed improvement after AVG training. Only three outcome measures tested impairments, and all others evaluated the children at the activity level of the ICF.
Level 4 studies
In the article extraction, an additional eight articles were case series studies with no comparison groups, which constituted level 4 evidence and could not be included in the main evidence table as per AACPDM methodology. 36, [47] [48] [49] [50] [51] [52] [53] Of these, seven studied children with CP, and one evaluated children with DCD. Results of these studies strongly reflected those reported above: outcome measures were varied, and results for AVG training generally showed improvement, with the exception of a few specific measures that showed no effect.
Challenges/limitations
Authors of the included articles identified similar limitations or threats to their studies across the different sample/ diagnostic populations. The primary limitation was low statistical power due to small sample sizes. 25, [37] [38] [39] [54] [55] [56] [57] Heterogeneity of participants was listed as a limitation in four studies. 26, 38, 55, 57 Researchers also listed challenges related to dosing of AVG as an intervention. They cited difficulty challenging the children enough for the treatment to have made a statistically significant difference in outcomes. 54, 56 The researchers also reported difficulty customizing the AVG enough to address children's individual limitations and to provide them with truly task-specific training. 37, 54, 56 Two studies remarked that the children may not have practiced for the required amount of time, either because of the motivation required to practice alone at home, 55 or because of false inflation of the actual amount of selfreported time playing. 56 Another limitation described was the lack of a true comparison group, which was reported in two studies. 39, 40 In the experimental design, another challenge cited was the inability to control for the daily life activity of these children. 38, 40, 58 These studies reported that if the children tended to play more with friends during the study time period, it may have altered their results. Three studies also listed a lack of blinding of assessors as a limitation. 25, 56, 58 
DISCUSSION
The purpose of this systematic review was to gather evidence about the use of AVG as a therapeutic intervention for improving motor outcomes in children with neurodevelopmental conditions. The feasibility of AVG use in all populations examined was affirmed by this review. In the body of literature searched, there was clear support for use of AVG to improve general motor function in children with neuromotor conditions. This suggests that AVG is a viable avenue to provide the practice levels required for motor improvement. However, the literature did not support use of AVG as a stand-alone intervention capable of creating permanent neuromotor improvements.
Additionally, AVG use in each population (CP, DCD, Down syndrome, or other) was generally supported by the research findings, but the overall strength of this body of literature was low. Of the articles that were included in this review, 14 were randomized control trials, of which 10 received moderate-or low-quality ratings. However, this body of literature also included two high-level systematic reviews that investigated use of AVG children with CP. 45, 46 Our finding that evidence was neither strong enough nor plentiful enough to form definitive recommendations was consistent with conclusions made in those previous reviews. However, the body of literature of our systematic review included a greater number of high-quality studies than previous reviews, indicating that the available evidence on AVG use is improving.
The four high-quality randomized control trials showed promising results for AVG training. 36, 40, 41, 58 Positive results were found for outcome measures evaluating balance, gross motor function, and upper-and lower-limb function. Although there were numerous tests and outcome measures used, most of these tools measured change at the level of impairment or capacity with regard to discrete skills. The only outcome suggesting that practice obtained through use of AVG might transfer to real-world function was the improvement in the Movement Assessment Battery for Children -Second Edition, the only outcome measure used in these four studies purporting to assess children at the ICF level of participation. None of the studies specifically tested whether AVG provided task-specific practice that carried over into real-world function. There was little or no overlap of outcome measures used among the four strong clinical trials, so results could not be combined for meta-analysis. Overall, the 49 outcome measures used across the 20 reviewed studies were generally heterogeneous, so it was not possible to make a definitive statement on whether AVG benefited these children in specific measures of upper extremity function, lower extremity function, or balance. In the combined body of literature, more outcome measures showed improvement than not, particularly those assessing lower extremity function. AVG does appear to be a promising treatment strategy to generally improve motor function in children with a variety of neuromotor conditions; however, more specific results cannot be derived. These findings reinforce the need for a standard set of outcome measures that can be used widely across research studies as well as in clinical practice touted in rehabilitation literature.
Standard physical therapy care served as the control condition for all experimental studies in which AVG was compared with other intervention strategies. Several studies showed that AVG and conventional therapy can be comparable in their results (some parameters improved more, others less), so it would be reasonable to include AVG in a training program for these children. The only repeated dosing protocol encountered in this body of literature was the delivery of AVG for 30 minutes, three times per week, for 6 weeks. 26 Our findings demonstrate that AVG holds promise as an intervention strategy for children with neurological conditions, but it was not significantly more efficacious or effective than traditional pediatric rehabilitation strategies in any of the studies reviewed.
We had hypothesized that AVG would largely be touted and examined as an adjunct to traditional therapies as part of a comprehensive plan of care, especially as a home program strategy used to increase the volume of practice of functional tasks. However, researchers in only four of the studies combined AVG training with standard care, all of which occurred in a clinical context. It would be helpful to examine the effects of AVG training as a home exercise program and adjunct to traditional physical therapy. This may give children the best of both worlds: skilled treatment from a trained therapist and the volume of task-specific practice provided with a home exercise program.
Owing to the heterogeneous nature of the populations, outcome measures, and protocols for AVG use, it is not possible to make formal recommendations about its use at this time. However, some trends do emerge as we consider the group of 20 studies as a whole. Direct supervision during AVG participation was associated with greater improvements in AVG-dependent motor outcomes. This may be true because the child's effort and volume of practice can be more effectively determined by their therapist. A second condition in which AVG seems to work well is when the games' level of difficulty can be adjusted to provide a personalized 'just right' challenge for each child. 36, 37 A third is outcome specificity, in which therapists choose specific games that target the individual child's desired outcomes. 37, 40, 44 On their own, the children tended to choose games that were easier for them to play, which did not challenge them to develop more skilled movement.
There was little variation in the type of AVG technology used across studies, with nearly all the 20 studies using the Nintendo Wii as it was commercially available. This may change with the development of new games using the Microsoft Xbox 360 Kinect or other gaming platforms that potentially offer more control to therapists, but these are not yet commercially available. 59 Like the 20 studies reviewed, this review has its own limitations. We did not consider non-English articles. We also did not include gray literature in the group of articles reviewed. These criteria may have limited our findings. Further, the largest quantities of evidence in this body of literature studied children with CP and (slightly less so) DCD. There were no studies at level 3 or higher evaluating the use of AVG for children with autism or epilepsy.
This review has shown that AVG is a feasible treatment strategy for several populations of children, and it is most likely a beneficial addition to traditional physical therapy. These findings suggest that AVG is most effective when used under the direct supervision of therapists who select the specific games to match each child's specific impairments and set the degree of difficulty for the children. However, specific recommendations on its use and effectiveness cannot be made, owing to the heterogeneous nature of the data.
Further research is warranted to explore the use of AVG, including larger sample sizes of children and the use of more homogenous outcome measures. Important questions to be asked in future studies include inquiries that illuminate optimal dosing of AVG, whether AVG actually provides the type of task-specific practice necessary to achieve transfer of skills to real-life function, and identification of the mechanisms by which AVG contributes to improved function. In addition, as AVG was shown to be potentially beneficial to samples of children with neurological motor dysfunction, its use in other subgroups of this population such as those with autism or epilepsy should be studied. Finally, the development of commercially available games with more control options available to the therapist is also justified by our findings.
ACKNOWLEDGEMENTS
We acknowledge support from the 2015 UNLVPT Student Opportunity Research Grant and technical assistance from health sciences librarian Xan Goodman. The authors have stated that they had no interests which might be perceived as posing a conflict or bias.
SUPPORTING INFORMATION
The following additional material may be found online: Figure S1 : Flow diagram of included articles 
